PlainRecalls
FDA Drug Moderate Class II Ongoing

Metformin Hydrochloride Extended-Release Tablets USP 750 mg, 30 Tablets bottle, Rx Only, Time-Cap Labs, Inc., Repackaged By: Northwind Pharmaceuticals North Blenheim NY 12131 NDC 70934-334-30

Reported: November 11, 2020 Initiated: October 8, 2020 #D-0056-2021

Product Description

Metformin Hydrochloride Extended-Release Tablets USP 750 mg, 30 Tablets bottle, Rx Only, Time-Cap Labs, Inc., Repackaged By: Northwind Pharmaceuticals North Blenheim NY 12131 NDC 70934-334-30

Reason for Recall

CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)

Details

Recalling Firm
Denton Pharma, Inc.
Units Affected
N/A
Distribution
Indiana - Nationwide.
Location
North Blenheim, NY

Frequently Asked Questions

What product was recalled?
Metformin Hydrochloride Extended-Release Tablets USP 750 mg, 30 Tablets bottle, Rx Only, Time-Cap Labs, Inc., Repackaged By: Northwind Pharmaceuticals North Blenheim NY 12131 NDC 70934-334-30. Recalled by Denton Pharma, Inc.. Units affected: N/A.
Why was this product recalled?
CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)
Which agency issued this recall?
This recall was issued by the FDA Drug on November 11, 2020. Severity: Moderate. Recall number: D-0056-2021.